Infection Current Awareness Update 02/08/2021
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Infection Current Awareness Update – 02/08/2021 Welcome to the weekly Infection Current Awareness Update (ICAU), produced by PHE Knowledge and Library Services. The purpose of this update is to provide you with the latest, best evidence about infection, to help you make informed decisions. Please note: PHE KLS has set up a separate COVID-19 Daily Alert of latest research. If you would like to receive this, please email libraries@phe.gov.uk. In addition to this, a page of resources about the coronavirus is available here. If you have any queries, please contact us at libraries@phe.gov.uk, and if you would like to request a literature search, please use the Knowledge and Library Services Enquiries Portal (PHE staff only). Please note that not all the articles and resources referred to in this alert are freely available. Some articles may require an Athens username and password, and for PHE and NHS staff, these can be obtained here. If you do not work for PHE or the NHS, you may want to approach your local health library service to discuss how you may have access to library services. COVID-19 related research • COVID-19 infection - 9 Infection-related guidance • American Society for Microbiology - 1 • British Association for Sexual Health and HIV - 1 • European Centre for Disease Prevention and Control - 3 • Infectious Diseases Society of America - 2 Infection-related journals • American Journal of Infection Control - 2 • Clinical Infectious Diseases - Advance Access - 20 • Clinical Infectious Diseases - Current Issue - 1 • Clinical Microbiology and Infection - 16 • Clinical Microbiology Reviews - Current Issue - 4 • Current Opinion in Microbiology - 5 • Current Opinion in Virology - 2 • Diagnostic Microbiology and Infectious Disease - 4 • Emerging Infectious Diseases Journal - ahead of print - 5 • Eurosurveillance latest updates - 4 • Infection - 3 • International Journal of Medical Microbiology - 1 • Infection Control & Hospital Epidemiology - FirstView Article - 13 • International Journal of Infectious Diseases - 25 • Journal of Clinical Microbiology - 8 • Journal of Hospital Infection - 1 • Journal of Infection - 16 • Journal of Virology Current Issue - 19 • Journal of Virology: Articles Published Ahead of Print - 3 • Lancet - 2 • Lancet: Infectious Diseases - 18 • Microbiology and Molecular Biology Reviews: Current Issue - 1 • Morbidity and Mortality Weekly Report (MMWR) - 6 • Nature Reviews Microbiology - Current Issue - 5 • New England Journal of Medicine - Current Issue - 3 • Scandinavian Journal of Infectious Diseases: Table of Contents - 22 • Sexually Transmitted Infection Online First - 2
NIS Affiliation • PubMed: NIS affiliation - 7 COVID-19 related research COVID-19 infection RT @GidMK: Cochrane review on ivermectin just dropped. This is the current gold-standard summary: "the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐ designed randomized trials." https://t.co/c9NUu2Fuex 30 Jul 2021 RT @GidMK: Cochrane review on ivermectin just dropped. This is the current gold-standard summary: "the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials." https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full NEW - #Ivermectin for preventing and treating #COVID19 - https://t.co/uNRPbPuX67 This @Cochrane_IDG meta-analysis looks at the evidence of 14 studies with 1678 participants that investigated ivermectin compared to no treatment, placebo, or usual care. https://t.co/Cwi0fycQOY 30 Jul 2021 NEW - #Ivermectin for preventing and treating #COVID19 - https://buff.ly/2VdJnqU This @Cochrane_IDG meta-analysis looks at the evidence of 14 studies with 1678 participants that investigated ivermectin compared to no treatment, placebo, or usual care. RT @JeremyFarrar: Ivermectin for preventing and treating COVID‐19 - Popp, M - 2021 | Cochrane Library @cochranecollab https://t.co/hq7b36tb5Z 29 Jul 2021 RT @JeremyFarrar: Ivermectin for preventing and treating COVID‐19 - Popp, M - 2021 | Cochrane Library @cochranecollab https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full#.YQE0BQayS2c.t witter Covid-19: NICE issues guidance on vaccine induced immune thrombocytopenia and thrombosis 29 Jul 2021 Patients who are acutely unwell with suspected vaccine induced immune thrombocytopenia and thrombosis (VITT) should be referred immediately to the emergency department, says new rapid guidance from... RT @nickmmark: New review of Ivermectin in COVID by @cochranecollab, thestandard in meta-analysis. It concludes "the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials." https://t.co/cH7wQ8mr9o 28 Jul 2021 RT @nickmmark: New review of Ivermectin in COVID by @cochranecollab, thestandard in meta- analysis. It concludes "the reliable evidence available does not support the use ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials." https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full RT @SMC_London: expert reaction to Cochrane review on ivermectin for preventing and treating COVID-19 https://t.co/ghH2itOOWL 28 Jul 2021 RT @SMC_London: expert reaction to Cochrane review on ivermectin for preventing and treating COVID-19 https://www.sciencemediacentre.org/expert-reaction-to-cochrane-review-on-ivermectin- for-preventing-and-treating-covid-19/
RT @GermHunterMD: : #Ivermectin proponents like to point to a supposedly
"Cochrane-level" systematic review & meta-analysis to support IVM for
treatment or prevention of COVID-19 Here's what the ACTUAL Cochrane
review says about ivermectin (emphasis mine) https://t.co/mqtcYorJz5
https://t.co/I4nEQzkcVN
28 Jul 2021
RT @GermHunterMD: : #Ivermectin proponents like to point to a supposedly "Cochrane-level"
systematic review & meta-analysis to support IVM for treatment or prevention of COVID-19 Here's
what the ACTUAL Cochrane review says about ivermectin (emphasis mine)
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full#.YQGDFVBAClh.t
witter
RT @CochraneLibrary: JUST PUBLISHED - #Ivermectin for preventing and
treating #COVID19 https://t.co/FR6Lc5HB7J New @Cochrane_IDG looked at
the evidence of 14 studies with 1678 participants that investigated ivermectin
compared to no treatment, placebo, or usual care. 1/4
https://t.co/sBqUCeT2cS
28 Jul 2021
RT @CochraneLibrary: JUST PUBLISHED - #Ivermectin for preventing and treating #COVID19
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub2/full New
@Cochrane_IDG looked at the evidence of 14 studies with 1678 participants that investigated
ivermectin compared to no treatment, placebo, or usual care. 1/4
New @CochraneENT Review highlights current uncertainty about treatments
to prevent lasting problems with sense of smell after COVID-19
https://t.co/nVp1GOy2v4 New studies will be added to this living systematic
review when available. @CochraneUK https://t.co/1pLV6698Wq
27 Jul 2021
New @CochraneENT Review highlights current uncertainty about treatments to prevent lasting
problems with sense of smell after COVID-19 https://buff.ly/3iN38h6 New studies will be added to this
living systematic review when available. @CochraneUK
[back to top]
Infection-related guidance
American Society for Microbiology
Guidelines for the Detection and Identification of Group B Streptococcus
29 Jul 2021
Updated July 2021. Streptococcus agalactiae or Group B Streptococcus (GBS) has long been a
leading cause of neonatal infection. ASM is responsible for maintaining and updating guidelines for
standard laboratory practices related to detection and identification of GBS.
[back to top]
British Association for Sexual Health and HIV
The BASHH Self-sampling recommendations have now been published on
the BASHH website. Please navigate to the Current Guidelines section.
27 Jul 2021
[back to top]
European Centre for Disease Prevention and ControlRapid Risk Assessment: Extreme rainfall and catastrophic floods in western
Europe
29 Jul 2021
Extreme rainfall on 14 and 15 July 2021 and subsequent flooding in Western Europe has taken a
high number of human lives and caused substantial damage to community infrastructure and the
environment. This rapid risk assessment focuses on the most common infectious diseases and
health risks associated with flood-affected areas, taking into account evidence from previous similar
events in Europe.
Hepatitis B - Annual Epidemiological Report for 2019
28 Jul 2021
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection.
Excluding the five countries that only reported acute cases, the number of cases, 29 518,
corresponds to a crude rate of 7.4 cases per 100 000 population.
Rapid Risk Assessment: COVID-19 outbreaks in long-term care facilities in
the EU/EEA in the context of current vaccination coverage
26 Jul 2021
Coronavirus disease (COVID-19) outbreaks in long-term care facilities (LTCFs) in European Union
and European Economic Area (EU/EEA) countries have caused significant morbidity and mortality
since the beginning of the COVID-19 pandemic.
[back to top]
Infectious Diseases Society of America
CID: A SARS-CoV-2 P.1 outbreak in a long-term care home suggests that
while vaccination is an essential tool in mitigating COVID-19, infection
prevention and control measures remain critical in this setting.
:https://t.co/KYVIG8cxxa #ClinInfectDis #IDSAJournals @HotaSusy
https://t.co/Lf3FbfW3yi
31 Jul 2021
CID: A SARS-CoV-2 P.1 outbreak in a long-term care home suggests that while vaccination is an
essential tool in mitigating COVID-19, infection prevention and control measures remain critical in this
setting. :https://bit.ly/3yaDoBU #ClinInfectDis #IDSAJournals @HotaSusy
A report in CID assessed cases of SARS-CoV-2 reinfection and persistence,
characterizing the hallmarks of reinfecting sequences and the rate of viral
evolution in persistent infection. :https://t.co/XgCElUuRJI #ClinInfectDis
#IDSAJournals @Dr_MChoudhary @charlesrcrain @DrJLi
https://t.co/h3q7GxuRvy
28 Jul 2021
A report in CID assessed cases of SARS-CoV-2 reinfection and persistence, characterizing the
hallmarks of reinfecting sequences and the rate of viral evolution in persistent infection.
:https://bit.ly/2V08xsW #ClinInfectDis #IDSAJournals @Dr_MChoudhary @charlesrcrain @DrJLi
[back to top]
Infection-related journals
American Journal of Infection Control
How infection present at time of surgery (PATOS) data impacts your surgical
site infection (SSI) standardized infection ratios (SIR), with focus on the
complex 30-day SSI SIR model
27 Jul 2021
This case study is part of a series centered on the Centers for Disease Control and Prevention's
National Healthcare Safety Network's (NHSN) health care-associated infection (HAI) surveillancedefinitions. This is the first analytic case study published in AJIC since the CDC/ NHSN updated its
HAI risk adjustment models and rebaselined the standardized infection ratios (SIRs) in 2015
A Four-year Follow-Up Survey of Antimicrobial Resistance Among
Acinetobacter baumannii complex From Inpatients in Southern Brazil
26 Jul 2021
: To determine the trends of antimicrobial resistance for Acinetobacter baumannii complex isolates
recovered from inpatients over a 4-year follow-up survey.
[back to top]
Clinical Infectious Diseases - Advance Access
Changes in health-related quality of life for HCV-infected people who inject
drugs on opioid agonist treatment following sustained virologic response
31 Jul 2021
AbstractBackgroundAlthough efforts to treat hepatitis C virus (HCV) in people who inject drugs
(PWID) yield high rates of sustained virologic response (SVR), the relationship between successful
HCV treatment and health-related quality of life (HRQOL) among PWID is poorly understood. This
study examined HRQOL changes throughout HCV treatment and post-treatment for PWID achieving
SVR
Genomic epidemiology and transmission dynamics of SARS-CoV-2 in
congregate healthcare facilities in Santa Clara County, California
30 Jul 2021
AbstractBackgroundOutbreaks of SARS-CoV-2 in long term care facilities (LTCFs) cause significant
morbidity and mortality. Mapping viral transmission within and between by combining genomic
sequencing with epidemiologic investigations enables targeting infection control interventions
Higher comorbidity burden predicts worsening neurocognitive trajectories in
people with HIV
30 Jul 2021
AbstractBackgroundAge-related comorbidities accumulate faster in people with HIV (PWH) than in
those without (PWoH). We evaluated whether a validated multimorbidity scale, the Charlson Index,
predicted neurocognitive trajectories in PWH.MethodsScaled scores a comprehensive
neuropsychological battery were averaged across all visits
Donor-derived ehrlichiosis: two clusters following solid organ transplantation
30 Jul 2021
AbstractEhrlichiosis has been infrequently described as transmissible through organ transplantation.
Two donor derived clusters of ehrlichiosis are described here. During the summer of 2020, two cases
of ehrlichiosis were reported to the Organ Procurement and Transplantation Network (OPTN) and the
Centers for Disease Control and Prevention (CDC) for investigation
Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized
Cancer Patients
30 Jul 2021
AbstractBackgroundThere is limited information on the risk of hospital-acquired COVID-19 among
high-risk hospitalized patients after exposure to an infected patient or healthcare worker (HCW) in a
non-outbreak setting.MethodsThis study was conducted at a tertiary care cancer center in New York
City from March 10, 2020, until February 28, 2021
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and
Isoniazid for Tuberculosis Prevention in Pregnant Women
29 Jul 2021
AbstractBackgroundPregnancy increases the risk of tuberculosis and its complications. A 3-month
regimen of weekly isoniazid and rifapentine (3HP) is safe and effective for tuberculosis prevention in
adults and children, including those with HIV, but 3HP has not been evaluated in pregnancy
Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence
in the US-born population aged 50 years or older in the United States
29 Jul 2021
AbstractBackgroundOlder age is a risk factor for TB in low incidence settings. Using data from the
U.S. National TB Surveillance System and American Community Survey, we estimated trends andracial/ethnic differences in TB incidence among US-born cohorts aged ≥50 years.Methods42,000 TB cases among US-born persons ≥50 years were reported during 2001–2019 Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study 28 Jul 2021 AbstractBackgroundThe epidemiology and risk of COVID-19 among travelers at international borders remain unclear.MethodsWe conducted descriptive and individually matched case-control studies using a nationwide register for COVID-19 testing of travelers from August 3 to October 31, 2020 at airport/port quarantine stations across Japan Leveraging a preexisting global infectious disease network for local decision- making during a pandemic 28 Jul 2021 AbstractEmerging infectious disease epidemics require a rapid response from health systems; however, evidence-based consensus guidelines are generally absent early in the course of events. Formed in 2017 by five high-level isolation units spanning three continents, the experience of the Global Infectious Disease Preparedness Network (GIDPN) early in the course of COVID-19 provides a model for Letter to the Editor: Response to Maziade et al; Enhanced Clostridioides difficile infection prevention with a pharmacy-controlled policy that adds a three-strain Lactobacillus probiotic concomitantly to antibiotic therapy 28 Jul 2021 Vaccine effectiveness against acute respiratory illness hospitalizations for influenza-associated pneumonia during the 2015-2016 to 2017-2018 seasons, US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) 28 Jul 2021 AbstractBackgroundEvidence for vaccine effectiveness (VE) against influenza-associated pneumonia has varied by season, location, and strain. We estimate VE against hospitalization for radiographically identified influenza-associated pneumonia during 2015-2016 to 2017-2018 seasons in the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa 27 Jul 2021 AbstractBackgroundOptimized tuberculosis (TB) screening in high burden settings is essential for case finding. We evaluated digital chest x-ray with computer-aided detection (CAD) software (d-CXR) for identifying undiagnosed TB in three primary health clinics in South Africa Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically and Etiologically Confirmed Outcomes: Systematic Literature Review and Re- analysis of Pneumococcal Conjugate Vaccine Efficacy Trials 27 Jul 2021 AbstractBackgroundVaccine regulatory decision-making is based on vaccine efficacy against etiologically confirmed outcomes; however, these outcomes may underestimate the preventable disease burden. To quantify this underestimation, we compared vaccine-preventable disease incidence (VPDI) of clinically defined outcomes to radiologically/etiologically confirmed outcomes Safety and Effectiveness of Intravenous Artesunate for Treatment of Severe Malaria in the United States —April 2019 through December 2020 27 Jul 2021 AbstractBackgroundSevere malaria can be deadly and requires treatment with intravenous artesunate (IVAS). The Centers for Disease Control and Prevention provided IVAS starting April 1, 2019 for all patients with severe malaria in the United States. This study describes the safety and effectiveness of IVAS in these patients Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager 26 Jul 2021
teenagerimmunocompromised childCOVID-19ARDSorganizing pneumonia
CD4 cell count: a critical tool in the HIV response
26 Jul 2021
CD4+ T-cell count at antiretroviral therapy initiation in the “treat all” era in rural
South Africa: an interrupted time series analysis
26 Jul 2021
AbstractBackgroundSouth Africa implemented universal test and treat (UTT) in September 2016 in
an effort to encourage earlier initiation of antiretroviral therapy (ART).MethodsWe therefore
conducted an interrupted time series (ITS) analysis to assess the impact of UTT on mean CD4 count
at ART initiation among adults ≥16 years old attending 17 public sector primary care services in rural
South
Impact of SARS-CoV-2 variant-associated RBD mutations on the
susceptibility to serum antibodies elicited by COVID-19 infection or
vaccination
26 Jul 2021
AbstractBackgroundSeveral SARS-CoV-2 lineages with mutations at the spike protein receptor
binding domain (RBD) have reduced susceptibility to antibody neutralization, and have been
classified as Variants of Concern (VOCs) or Variants of Interest (VOIs). Here, we systematically
compared the neutralization susceptibility and RBD binding of different VOCs/VOIs, including B.1.617
Chronic disease and immunosuppression increase the risk for non-vaccine
serotype pneumococcal disease – a nationwide population-based study
24 Jul 2021
AbstractBackgroundDemography is changing, with people living longer with comorbidities. In this
nationwide population-based study, we investigated the serotype-specific invasive pneumococcal
disease (IPD) risk in individuals with comorbidities, and effects of the pneumococcal conjugated
vaccine (PCV) child immunization program
Vikela Ekhaya: a novel, community-based, tuberculosis contact management
program in a high burden setting
24 Jul 2021
AbstractBACKGROUNDThe prevention of tuberculosis (TB) in child contacts of TB cases and people
living with HIV is a public health priority, but global access to TB preventive therapy (TPT) remains
low. In 2019, we implemented Vikela Ekhaya, a novel community-based TB contact management
program in Eswatini designed to reduce barriers to accessing TPT
[back to top]
Clinical Infectious Diseases - Current Issue
Introduction to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS
CoV-2) Supplement
30 Jul 2021
In this supplement to Clinical Infectious Diseases, we are pleased to present 8 manuscripts that
informed the scientific underpinning of nonbiological interventions that have become key components
of the public health response to the coronavirus disease 2019 (COVID-19) pandemic
[back to top]
Clinical Microbiology and Infection
Effect of didecyl dimethyl ammonium chloride (DDAC)-impregnated washcloth
wipe whole-body bathing (WBB) on catheter-related blood stream infections
(CRBSI) and central venous line-associated infections (CLAI) in adult
intensive care units (ICUs)
30 Jul 2021
Publication date: Available online 30 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Fabian von Dehn, Nico T. Mutters, Vanessa Eichel, Uta Merle, Thorsten Brenner, Michael Nafe, Anja
Sander, Martin Wolkewitz, Uwe FrankCMI: how did we do in 2020? 30 Jul 2021 Publication date: Available online 29 July 2021Source: Clinical Microbiology and InfectionAuthor(s): J. Friedman, L. Leibovici Clinical microbiology laboratories in low-resource settings, it is not only about equipment and reagents, but also good governance for sustainability 29 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Heiman F.L. Wertheim, Huong Vu Thi Lan, Ed J. Kuijper Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials 29 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Gehad Mohamed Tawfik, Marwa Biala, Yomna Mahmoud Yousef, Ranjit Tiwari, Monica Dobs, Caroline Ibrahim Lotfy, Doha Ahmed Farrag, Anh Tran Hue, Rie Roselyne Yotsu, Nguyen Tien Huy Standard therapy of Mycobacterium avium complex pulmonary disease shows limited efficacy in an open source hollow fiber system that simulates human plasma and epithelial lining fluid pharmacokinetics 29 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Mike Marvin Ruth, Jelmer Raaijmakers, Erik van den Hombergh, Rob Aarnoutse, Elin M. Svensson, Budi O. Susanto, Ulrika SH. Simonsson, Heiman Wertheim, Wouter Hoefsloot, Jakko van Ingen Can asia now learn from the experience of the west? 28 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Julian W. Tang, Samantha Wu, Kin On Kwok Antibody response induced by the BNT162b2 mRNA COVID-19 vaccine in a cohort of health-care workers, with or without prior SARS-CoV-2 infection: a prospective study 28 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Dora Buonfrate, Chiara Piubelli, Federico Gobbi, Davide Martini, Giulia Bertoli, Tamara Ursini, Lucia Moro, Niccolò Ronzoni, Andrea Angheben, Paola Rodari, Chiara Cardellino, Francesca Tamarozzi, Stefano Tais, Eleonora Rizzi, Monica Degani, Michela Deiana, Marco Prato, Ronaldo Silva, Zeno Bisoffi Limitations of Classification and Regression Tree analysis in Vancomycin Exposure-Response relationship studies: insights from data simulation 28 Jul 2021 Publication date: Available online 28 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Bruce R. Dalton, Anish Krishnan, Jackson J. Stewart, Sarah CJ. Jorgensen Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: A multicentre European study 27 Jul 2021 Publication date: Available online 26 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Daniel Martak, Julia Guther, Tess D. Verschuuren, Benoit Valot, Nadine Conzelmann, Stefanie Bunk, M. Eugenia Riccio, Elena Salamanca, Alexandre Meunier, Charles P. Henriot, Caroline Pressacco Brossier, Xavier Bertrand, Ben S. Cooper, Stephan Harbarth, Evelina Tacconelli, Ad C Effect of discontinuation of an antimicrobial stewardship program on the antibiotic usage pattern 27 Jul 2021 Publication date: Available online 27 July 2021Source: Clinical Microbiology and InfectionAuthor(s): Wooyoung Jang, Hyeonjun Hwang, Hyun-uk Jo, Yong-Han Cha, Bongyoung Kim Bacterial and fungal bloodstream infections in solid organ transplant recipients: result from a Danish cohort with nationwide follow-up
27 Jul 2021
Publication date: Available online 27 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Dina Leth Møller, Søren Schwartz Sørensen, Michael Perch, Finn Gustafsson, Omid Rezahosseini,
Andreas Dehlbæk Knudsen, Thomas Scheike, Jenny Dahl Knudsen, Jens Lundgren, Allan
Rasmussen, Susanne Dam Nielsen
Borrelia mayonii – A cause of Lyme borreliosis that can be visualized by
microscopy of thin blood films
27 Jul 2021
Publication date: Available online 27 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Bobbi S. Pritt, Emily C. Fernholz, Adam J. Replogle, Luke C. Kingry, Michael P. Sciotto, Jeannine M.
Petersen
Intravenous immunoglobulins for the treatment of the hyper-inflammatory
response in COVID-19. Another failure of immunomodulatory therapy?
26 Jul 2021
Publication date: Available online 26 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Francisco López-Medrano, José María Aguado
Clinical and laboratory features of Strongyloides stercoralis infection at
diagnosis and after treatment: a systematic review and meta-analysis
26 Jul 2021
Publication date: Available online 26 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Dora Buonfrate, Andrea Fittiplado, Erika Vlieghe, Emmanuel Bottieau
Quo vadis clinical diagnostic microbiology?
26 Jul 2021
Publication date: Available online 26 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Sara Haag, Susanne Häussler
The potential of SARS-CoV-2 antigen-detection tests in the screening of
asymptomatic persons
26 Jul 2021
Publication date: Available online 26 July 2021Source: Clinical Microbiology and InfectionAuthor(s):
Jonas Wachinger, Ioana Diana Olaru, Susanne Horner, Paul Schnitzler, Klaus Heeg, Claudia M.
Denkinger
[back to top]
Clinical Microbiology Reviews - Current Issue
Transmission of Infections during Cardiopulmonary Resuscitation
28 Jul 2021
Clinical Microbiology Reviews, Ahead of Print.
Prion Dissemination through the Environment and Medical Practices: Facts
and Risks for Human Health
28 Jul 2021
Clinical Microbiology Reviews, Ahead of Print.
The Standardization and Control of Serology and Nucleic Acid Testing for
Infectious Diseases
28 Jul 2021
Clinical Microbiology Reviews, Ahead of Print.
SARS-CoV-2 Antiviral Therapy
28 Jul 2021
Clinical Microbiology Reviews, Ahead of Print.
[back to top]
Current Opinion in Microbiology
Protein stoichiometry, structural plasticity and regulation of bacterial
microcompartments
01 Aug 2021Publication date: October 2021Source: Current Opinion in Microbiology, Volume 63Author(s): Lu-
Ning Liu, Mengru Yang, Yaqi Sun, Jing Yang
Metabolic stringent response in intracellular stages of Leishmania
01 Aug 2021
Publication date: October 2021Source: Current Opinion in Microbiology, Volume 63Author(s):
Eleanor C Saunders, Marijke F Sernee, Julie E Ralton, Malcolm J McConville
Eradicating biofilm infections: an update on current and prospective
approaches
30 Jul 2021
Publication date: October 2021Source: Current Opinion in Microbiology, Volume 63Author(s): Ronni
A G da Silva, Irina Afonina, Kimberly A Kline
Stochastic response of bacterial cells to antibiotics: its mechanisms and
implications for population and evolutionary dynamics
27 Jul 2021
Publication date: October 2021Source: Current Opinion in Microbiology, Volume 63Author(s):
Tatsuya Akiyama, Minsu Kim
The spatial organization of microbial communities during range expansion
27 Jul 2021
Publication date: October 2021Source: Current Opinion in Microbiology, Volume 63Author(s):
Weirong Liu, Taku A. Tokuyasu, Xiongfei Fu, Chenli Liu
[back to top]
Current Opinion in Virology
Non-structural protein 5 (NS5) as a target for antiviral development against
established and emergent flaviviruses
01 Aug 2021
Publication date: October 2021Source: Current Opinion in Virology, Volume 50Author(s): Philipe O
Fernandes, Marcelo A Chagas, Willian R Rocha, Adolfo H Moraes
Mechanisms of HCV resistance to broadly neutralizing antibodies
28 Jul 2021
Publication date: October 2021Source: Current Opinion in Virology, Volume 50Author(s): Nicole
Frumento, Andrew I Flyak, Justin R Bailey
[back to top]
Diagnostic Microbiology and Infectious Disease
Detection of SARS-CoV-2 infection in asymptomatic populations using the
DiaSorin Molecular Simplexa and Roche Cobas EUA assays
01 Aug 2021
Publication date: Available online 31 July 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Stella Antonara, Patrick Ozbolt, Lorie Landon, Lisa Fatica, Tamra Pleasant,
Juanita Swickard, Andrew Drury, Nicholas Wongchaoart, Kendall W Cradic
Trends of Major Antimicrobial Resistance Phenotypes in Enterobacterales
and Gram-negative Non-fermenters from ATLAS and EARS-Net Surveillance
Systems: Italian vs. European and Global data, 2008-2018
01 Aug 2021
Publication date: Available online 30 July 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Gian Maria Rossolini, Marzena Bochenska, Laura Fumagalli, Michael Dowzicky
Evaluation of the Abbott PanbioTM COVID-19 Ag Rapid Antigen Test for the
Detection of SARS-CoV-2 in Asymptomatic Canadians
01 Aug 2021
Publication date: Available online 31 July 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Julie L V Shaw, Vincent Deslandes, Jennifer Smith, Marc DesjardinsComparative Genomics of Enterobacter cloacae complex before and after
acquired clinical resistance to Ceftazidime-Avibactam
01 Aug 2021
Publication date: Available online 31 July 2021Source: Diagnostic Microbiology and Infectious
DiseaseAuthor(s): Fiona Senchyna, Fiona B. Tamburini, Kanagavel Murugesan, Nancy Watz, Ami S.
Bhatt, Niaz Banaei
[back to top]
Emerging Infectious Diseases Journal - ahead of print
Human and Porcine Transmission of Clostridioides difficile Ribotype 078,
Europe
01 Aug 2021
G. Moloney et al.
Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection
among Camel Populations, Southern Jordan, 2014–2018
01 Aug 2021
P. Holloway et al.
Fatal Exacerbations of Systemic Capillary Leak Syndrome Complicating
Coronavirus Disease
27 Jul 2021
P. C. Cheung et al.
Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute
Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
27 Jul 2021
S. Monge et al.
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after
Treatment for COVID-19
27 Jul 2021
D. Focosi et al.
[back to top]
Eurosurveillance latest updates
Vaccine breakthrough infection and onward transmission of SARS-CoV-2
Beta (B.1.351) variant, Bavaria, Germany, February to March 2021
29 Jul 2021
A breakthrough infection occurred in a fully Comirnaty (BNT162b2) vaccinated healthcare worker with
high levels of neutralising antibodies with the SARS-CoV-2 B.1.351 (Beta) variant in February 2021.
The infection was subsequently transmitted to their unvaccinated spouse. Sequencing revealed an
identical virus in both spouses, with a match of all nine single nucleotide polymorphisms typical for B
Authors’ correction for Euro Surveill. 2021;26(29)
29 Jul 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a
secondary care hospital in Finland, May 2021
29 Jul 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a
secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths
in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully
vaccinated
Authors’ correction for Euro Surveill. 2021;26(24)
29 Jul 2021
[back to top]Infection
Characteristics of viral pneumonia in the COVID-19 era: an update
27 Jul 2021
Abstract Influenza virus, rhinovirus, and adenovirus frequently cause viral pneumonia, an important
cause of morbidity and mortality especially in the extreme ages of life. During the last two decades,
three outbreaks of coronavirus-associated pneumonia, namely Severe Acute Respiratory Syndrome,
Middle-East Respiratory Syndrome, and the ongoing Coronavirus Infectious Disease—2019 (COVID-
19) were
Eosinophilic pustular folliculitis (EPF) in a patient with HIV infection
27 Jul 2021
Abstract Eosinophilic pustular folliculitis is a chronic, recurrent dermatosis, of unknown etiology,
which is histologically characterized by folliculotropic inflammatory infiltrates with admixed eosinophils
in the dermis. It has often presented with immunosuppression and especially with HIV-Infection. In
the HAART-era, eosinophilic pustular folliculitis has become a rarity
Correctly performed nasal swabs
27 Jul 2021
Abstract Background As the incidence of new cases of coronavirus disease increased exponentially,
the use of viral swabs to collect nasopharyngeal specimens are increasing drastically. Therefore,
healthcare workers military staff and uneducated nonprofessional’s were ordered to make this swabs
[back to top]
International Journal of Medical Microbiology
hns mRNA downregulates the expression of galU and attenuates the motility
of Salmonella enterica serovar Typhi
27 Jul 2021
Publication date: Available online 26 July 2021Source: International Journal of Medical
MicrobiologyAuthor(s): Xin Zhao, Fanfan Yang, Yurou Wang, Ying Zhang
[back to top]
Infection Control & Hospital Epidemiology - FirstView Article
Diversity in probiotics and diversity in clinical trials: Opportunities for
improvement
30 Jul 2021
Published online by Cambridge University Press:
Efforts to regulate antibiotic misuse in hospitals: A history
30 Jul 2021
Published online by Cambridge University Press:
An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in
Japan
30 Jul 2021
Published online by Cambridge University Press:
Association between Clostridioides difficile infection testing results and
decision to treat
30 Jul 2021
Published online by Cambridge University Press:
Antibiotic prophylaxis in beta-lactam allergic patients undergoing cesarean
and vaginal delivery: An opportunity for stewardship
29 Jul 2021
Published online by Cambridge University Press:
Change in trends of hospitalizations and deaths with mention of Clostridioides
difficile infection in northeastern Italy, 2008–2019
29 Jul 2021
Published online by Cambridge University Press:Clinical prediction of bacteremia and early antibiotics therapy in patients with
solid tumors
28 Jul 2021
Published online by Cambridge University Press:
SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a
large Belgian hospital network
22 Jul 2021
Published online by Cambridge University Press:
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence
among laboratory staff: Safe handling of coronavirus disease 2019 (COVID-
19) samples
21 Jul 2021
Published online by Cambridge University Press:
Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-
CoV-2) transmission from a highly infectious patient with undiagnosed
coronavirus disease 2019 (COVID-19) in a positive-pressure room
21 Jul 2021
Published online by Cambridge University Press:
Feasibility and safety of discontinuation of isolation precaution policy for
coronavirus disease 2019 (COVID-19) patients from COVID-19 units to
general medical units in Thailand
21 Jul 2021
Published online by Cambridge University Press:
Disproportionate coronavirus disease 2019 (COVID-19) vaccine distribution—
A great threat to low- and middle-income countries
15 Jul 2021
Published online by Cambridge University Press:
Adverse events and humoral response after two doses of severe acute
respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital
personnel of a cardiopulmonary tertiary-care center
15 Jul 2021
Published online by Cambridge University Press:
[back to top]
International Journal of Infectious Diseases
IgG Antibody response to the Sputnik V vaccine: previous SARS-CoV-2
seropositive individuals might need just one vaccine dose.
01 Aug 2021
Publication date: Available online 31 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Franklin Claro, Douglas Silva, Melissa Rodriguez, Rafael Rangel, Jacobus H. de
Waard
Prevalence and Genotype Distribution of Human Papillomavirus Infection
among 12,076 Iranian Women
01 Aug 2021
Publication date: Available online 31 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Fatemeh Bitarafan, Mohammad Reza Hekmat, Mehrnoosh Khodaiean, Ehsan
Razmara, Tahereh Ashrafganjoei, Mitra Modares Gilani, Mitra Mohit, Soheila Aminimoghaddam,
Fatemeh Cheraghi, Raziyeh Khalesi, Parnian Rajabzadeh, Soheila Sarmadi, Masoud Garshasbi
Repeat assessment of physical examination findings among HIV-uninfected
children in Malawi with chest-indrawing pneumonia
01 Aug 2021
Publication date: Available online 31 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Amy Sarah Ginsburg, Tisungane Mvalo, Susanne MayAbsence of SARS-CoV-2 antibodies in pre-pandemic plasma from children and adults in Vietnam 01 Aug 2021 Publication date: Available online 31 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Nguyen Van Vinh Chau, Le Nguyen Thanh Nhan, Lam Anh Nguyet, Nguyen Thi Kha Tu, Nguyen Thi Thu Hong, Dinh Nguyen Huy Man, Dinh Thi Bich Ty, Le Nguyen Truc Nhu, Lam Minh Yen, Truong Huu Khanh, Du Tuan Quy, Ngo Ngoc Quang Minh, Nguyen Thi Han Ny, Danielle Anderson, Lin-Fa Wang, H Effect of Non-lockdown Social Distancing and Testing-Contact Tracing During a COVID-19 Outbreak in Daegu, South Korea, February to April 2020: A Modeling Study 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Yi-Hsuan Chen, Chi-Tai Fang, Yu-Ling Huang Long term Survival of Treated Tuberculosis patients in comparison to General Population in South India – a Matched Cohort study 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Sriram Selvaraju, Kannan Thiruvengadam, Basilea Watson, Nataraj Thirumalai, Muniyandi Malaiswamy, Chandrasekaran Vedachalam, Soumya Swaminathan, Chandrasekaran Padmapriyadarsini SARS-CoV-2 in transit: characterization of SARS-CoV-2 genomes from Venezuelan migrants in Colombia 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Luz H. Patiño, Nathalia Ballesteros, Marina Muñoz, Sergio Castañeda, Carolina Hernández, Sergio Gomez, Carolina Florez, Angelica Rico, Liseth Pardo, Carlos E. Hernandez- Pereira, Lourdes Delgado-Noguera, Maria E. Grillet, Matthew M Symptomatic Bradycardia in Covid-19 Hospitalized Patients: a Case Series 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Muzakkir Amir, Hendry Yoseph, Aulia Thufael Al Farisi, James Klemens Phieter Phie, Andi Tiara Salengke Adam Corrigendum to “Tuberculosis among children and adolescents in Rio de Janeiro, Brazil – Focus on extrapulmonary disease” [Int J Infect Dis 105 (2021) 105-112] 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Márcia Cortez Bellotti de Oliveira, Clemax Couto Sant'Anna, Ronir Luiz Raggio, Afrânio Lineu Kritski DimachkieSpectrum of Acute Neuropathy Associated with Covid-19: Clinical and electrophysiological study of 13 patients from a single center 30 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Sai Deepak Yaranagula, Venkata Krishna Chaitanya Koduri Risk factors for hospitalization and mortality due to dengue fever in a Mexican population: a retrospective cohort study. 29 Jul 2021 Publication date: Available online 28 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Rodrigo Fonseca-Portilla, Mercedes Martínez-Gil, Dan Morgenstern-Kaplan Treatment of SARS-CoV-2 Relapse with Remdesivir and Neutralizing Antibodies Cocktail in a Patient with X-Linked Agammaglobulinemia 29 Jul 2021 Publication date: Available online 28 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Emanuele Palomba, Maria Carrabba, Gianluca Zuglian, Laura Alagna, Paola
Saltini, Valeria Fortina, Cinzia Hu, Alessandra Bandera, Giovanna Fabio, Andrea Gori, Antonio Muscatello Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222 29 Jul 2021 Publication date: Available online 28 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Thomas Perkmann, Nicole Perkmann-Nagele, Patrick Mucher, Astrid Radakovics, Manuela Repl, Thomas Koller, Galateja Jordakieva, Oswald F Wagner, Christoph J Binder, Helmuth Haslacher Association of public health interventions and COVID-19 incidence in Vietnam, January to December 2020 29 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Ha-Linh Quach, Khanh Cong Nguyen, Ngoc-Anh Hoang, Thai Quang Pham, Duong Nhu Tran, Mai Thi Quynh Le, Hung Thai Do, Chien Chinh Vien, Lan Trong Phan, Nghia Duy Ngu, Tu Anh Tran, Dinh Cong Phung, Quang Dai Tran, Tan Quang Dang, Duc-Anh Dang, Florian Vogt Tuberculosis recurrence over 7-year follow-up period in successfully treated patients in a routine programme setting in China: a prospective longitudinal study 29 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Yan Lin, Haoxiang Lin, Lixin Xiao, Yongming Chen, Xu Meng, Xianglin Zeng, Chun Chang, Grania Brigden Influence of HIV infection on the distribution of high-risk HPV types among women with cervical precancerous lesions in Yaounde, Cameroon 29 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Richard TAGNE SIMO, Fonyuy B. KIAFON, Charlette NANGUE, André P. GOURA, Jackson L. EBUNE, Moki C. USANI, Armel H. NWABO KAMDJE, Paul F. SEKE ETET, Phélix B. TELEFO The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan Africa 29 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Sabina Rodriguez Velásquez, Léa Jacques, Jyoti Dalal, Paolo Sestito, Zahra Habibi, Akarsh Venkatasubramanian, Benedict Nguimbis, Sara Botero Mesa, Cleophas Chimbetete, Olivia Keiser, Benido Impouma, Franck Mboussou, George Sie William, Nsenga Ngoy, Ambrose Talisuna, Abdou Salam Gueye, The negative impact of increasing age and underlying cirrhosis on sensitivity of adenosine deaminase in the diagnosis of tuberculous peritonitis: a cross- sectional study in eastern China 29 Jul 2021 Publication date: Available online 29 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Jian Sun, Huatang Zhang, Zhiwei Song, Lei Jin, Jian Yang, Jun Gu, Dan Ye, Xueping Yu, Jianghua Yang Group B Streptococcus Awareness Month: Vaccine and Challenges Underway 28 Jul 2021 Publication date: Available online 27 July 2021Source: International Journal of Infectious DiseasesAuthor(s): Tatiana Castro Abreu Pinto, Laura Maria Andrade Oliveira, Natália Silva da Costa, Amanda de Assis Rocha, André Rio Tinto de Matos Freire, Carollina Moreira Franquelino Gutierrez, Crislaine Mateus dos Santos, Danielle Cristina dos Santos Silva Alvim, Débora da Costa Morato Nery, Isabella
A Five-day Course of Ivermectin may Reduce the Duration of COVID-19
Illness
27 Jul 2021
Publication date: Available online 26 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Sabeena Ahmed, Wasif Ali Khan
Covid-19: An extra-terrestrial disease?
27 Jul 2021
Publication date: Available online 26 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Elisabeth Paul, Garrett W. Brown, Mélanie Dechamps, Andreas Kalk, Pierre-
François Laterre, Bernard Rentier, Valéry Ridde, Martin Zizi
Influenza immunization and COVID-19 – can viral structure be responsible for
the effect?
27 Jul 2021
Publication date: Available online 26 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Ivan Ilic, Dragana Unic Stojanovic, Goran Loncar
Can seasonal influenza vaccine for 2019/2020 has cross reactivity with some
of SARS-CoV-2 proteins?
27 Jul 2021
Publication date: Available online 26 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Milad Zandi, Emad Behboudi, Saber Soltani
Validation and implementation of a direct RT-qPCR method for rapid
screening of SARS-CoV-2 infection by using non-invasive saliva samples
26 Jul 2021
Publication date: Available online 25 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Pedro Brotons, Amaresh Perez-Argüello, Cristian Launes, Francesc Torrents,
Maria Pilar Subirats, Jesica Saucedo, Joana Claverol, Juan Jose Garcia-Garcia, Gil Rodas, Vicky
Fumado, Iolanda Jordan, Eduard Gratacos, Quique Bassat, Carmen Muñoz-Almagro
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 vaccine in
Vaccinee in Saudi Arabia
26 Jul 2021
Publication date: Available online 25 July 2021Source: International Journal of Infectious
DiseasesAuthor(s): Salma AlBahrani, Ali AlBarraK, Othman Ali Alghamdi, Mesfer Abdullah alghamdi,
Fatimah H. Hakami, Asmaa K. Al Abaadi, Sausan A. Alkhrashi, Mansour Y. Alghamdi, Meshael M.
Almershad, Mansour Moklif Alenazi, Mohamed Hany ElGezery, Arulanantham Zechariah Jebakumar,
Jaffar A. Al-Tawfiq
[back to top]
Journal of Clinical Microbiology
Trichomonas vaginalis detection in urogenital specimens from symptomatic
and asymptomatic men and women using the cobas TV/MG test
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Longitudinal Mycobacterium tuberculosis specific interferon-γ responses in
Ethiopian HIV-negative women during pregnancy and post-partum
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Fast and sensitive real-time PCR detection of major antiviral drug-resistance
mutations in chronic hepatitis B patients using a predesigned panel of
Locked-Nucleic-Acid TaqMan probes
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Performance characteristics of the Roche Diagnostics cobas® Liat® PCR
System as a COVID-19 screening tool for hospital admissions in a regional
healthcare delivery system28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Simultaneous determination of Mycobacterium leprae drug resistance and
single nucleotide polymorphism genotype using nested multiplex PCR with
amplicon sequencing
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Assessment of SARS-CoV-2 genome sequencing: quality criteria and low
frequency variants
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Antimicrobial resistance spectrum conferred by pRErm46 of emerging
macrolide (multidrug)-resistant Rhodococcus equi
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
Identification of molds with MALDI-TOF mass spectrometry: performance of
the newly developed MSI-2 application in comparison with the Bruker
filamentous fungi database and MSI-1
28 Jul 2021
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
[back to top]
Journal of Hospital Infection
The relationship between diabetes and surgical site infection following
coronary artery bypass graft surgery in current-era models of care
27 Jul 2021
Although diabetes is a recognised risk factor for post-operative infections, the seminal Portland
Diabetic Project studies in cardiac surgery demonstrated intravenous insulin infusions following open-
cardiac surgery achieved near normal glycaemia and decreased deep sternal wound infection to
similar rates to those without diabetes.
[back to top]
Journal of Infection
Epidemiological characteristics of Varicella before and after the
implementation of two-dose vaccination schedule in Chaoyang District,
Beijing, 2007-2019
29 Jul 2021
Dear Editor
CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection
Irrespective of HIV infection in low TB burden countries
29 Jul 2021
Approximately one-quarter of the world's population is infected with Mycobacterium tuberculosis (M.
tb), harbouring a risk of progression from latent tuberculosis infection (LTBI) to tuberculosis (TB)
disease. Disease progression is associated with immunosuppression in general, but HIV-infected
individuals have a 19 fold risk compared to HIV-uninfected people (1)
Post-SARS-CoV-2 vaccination specific antibody decrease : let's get the half-
full glass perspective
28 Jul 2021
We read with great interest the papers recently published in the Journal of Infection tackling the issue
of post-vaccination antibody levels to SARS-CoV-2 spike protein (1,2). Our attention was caught by
the report from Favresse et al. (1) showing that high dilution of the tested samples provided a more
accurate appreciation of post-vaccination antibody levelsLongitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia 27 Jul 2021 In this journal, Walsh and colleagues (1) recently reviewed the evidence supporting that immunocompromised patients may remain positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection for long periods of time, up to 20 days SARS-CoV-2 viral dynamics in infections with Alpha and Beta variants of concern in the French community 27 Jul 2021 We read with interest the article by Tang et al. on the multiple introductions of variant B.1.351 into the UK1. As SARS-CoV-2 variants of concern rapidly spread internationally, it is important to know if increased transmissibility2–4 and virulence5 is associated with higher viral load to understand pathogenesis and adapt if necessary the duration of isolation of infected individuals Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection 27 Jul 2021 Latent Tuberculosis infection (LTBI) is known to infect about a quarter of the world's population, while SARS-CoV-2 has thus far infected over 130 million people worldwide(1, 2). Although both LTBI and SARS-CoV-2 are co-prevalent in many parts of the world, there is a paucity of information about the effect of co-infection on the host immune responses The impact of an antifungal stewardship team on voriconazole therapeutic drug monitoring in a UK tertiary hospital 27 Jul 2021 In this Journal Schelenz and colleagues reported that only 71% of laboratories provided advice on voriconazole therapeutic drug monitoring (TDM)[1]. It also highlighted issues of when to perform it [1]. Voriconazole is a triazole antifungal licensed for the prevention and treatment of invasive aspergillosis Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021 27 Jul 2021 The COVID-19 pandemic has put unprecedented strain on health systems around the world, and the emergence of variants of concern (VOC) remains an area of substantial concern as we continue to battle the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This includes lineage B.1.1.7 (alpha variant), first detected in south-east England in September 2020 (1) Potential impact of COVID-19 Pandemic on escalating antimicrobial resistance in Pakistan 27 Jul 2021 We read with interest the article recently published in this journal, entitle underestimation of co- infection in COVID-19 due to non-discriminatory use of antibiotic by Chien et al [1]. Authors discussed the use of antibiotics and risk of antimicrobial resistance during the COVID-19 pandemic and in this letter we explored the possible effects of COVID-19 pandemic on antimicrobial resistance (AMR) Emergence of Novel Recombinant Type 2 Porcine Reproductive and Respiratory Syndrome Viruses with high pathogenicity for piglets in China 27 Jul 2021 Several studies in this journal reported genetic diversity of African swine fever virus (ASFV) genomes and suggested ASFV was a potential threat to unaffected countries in Asia.1-3 Porcine reproductive and respiratory syndrome (PRRS), caused by porcine reproductive and respiratory syndrome virus (PRRSV), is another swine viral disease causing huge economic losses to the global swine industry Impact of treatment duration on recurrence of chronic pulmonary aspergillosis 27 Jul 2021 Chronic pulmonary aspergillosis (CPA) is usually a chronic progressive pulmonary disease caused by the Aspergillus species, commonly A. fumigatus. It occurs in adulthood and especially in individuals with preexisting pulmonary conditions. 1-3 Recent European guidelines categorized CPA into several phenotypes, i.e
Immune responses and reactogenicity after ChAdOx1 in individuals with past
SARSCoV-2 infection and those without
27 Jul 2021
We have read the article by E. Sansone, et al.1 with great interest. The authors found the significant
protective effect of BNT162b2 vaccination against SARS-CoV-2 infection and symptom development
after SARS-CoV-2 infection among healthcare workers (HCWs)
Epidemiological data and genome sequencing reveals that nosocomial
transmission of SARS-CoV-2 is underestimated and mostly mediated by a
small number of highly infectious individuals.
27 Jul 2021
Limiting acquisition of SARS-CoV-2 by patients and staff in hospitals is an infection prevention and
control (IPC) priority. Despite robust efforts, both patients and staff are infected in hospitals; 10-40%
of hospital-diagnosed COVID-19 cases are thought to have been acquired in hospital, with 8700
deaths following nosocomial infection reported in the UK, [1–4] and higher rates of seroconversion
Emerging Polio Hotspots in Pakistan: Challenges and the way forward
26 Jul 2021
We read with great interest the article entitled "Impact of COVID-19 pandemic on Measles
surveillance in Pakistan" by Rana M.S. et al. The authors of this article discuss the various infectious
diseases that surfaced during the COVID-19 pandemic.1 Therefore, the current article will spotlight
the re-emergence of polio in Pakistan, which is another serious public health concern.
Cross reactivity of serological response to SARS-CoV-2 vaccination with viral
variants of concern detected by lateral flow immunoassays
26 Jul 2021
The Coronavirus 2 (SARS-CoV-2) pandemic continues to affect almost every country in the world (1).
In the UK, two main vaccines have formed the basis of the national immunisation strategy: the
AstraZeneca ChAdOx1 nCoV-19 vaccine (AZ) (2) and the Pfizer-BioNtech COVID-19 vaccine
(PFZ)(3)
Extrahepatic manifestations related to hepatitis E virus infection and their
triggering mechanisms
25 Jul 2021
In the late 1970s, a new intestinally transmitted viral hepatitis that was not related to blood
transfusion was first discovered in India, and was named as hepatitis E.1 Hepatitis E virus (HEV) was
subsequently discovered by investigators in 1983 during an unexplained hepatitis outbreak among
Soviet soldiers.2 Nearly 10 years later, the viral genome of HEV was successfully sequenced
[back to top]
Journal of Virology Current Issue
B-Catenin Signaling Regulates the In Vivo Distribution of Hepatitis B Virus
Biosynthesis across the Liver Lobule
28 Jul 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Hemagglutinins of avian influenza viruses are proteolytically activated by
TMPRSS2 in human and murine airway cells
28 Jul 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Virology Laboratory Guidelines
28 Jul 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
Ebola virus requires phosphatidylserine scrambling activity for efficient
budding and optimal infectivity
28 Jul 2021
Journal of Virology, Volume 0, Issue ja, -Not available-.
An infectious Rous Sarcoma Virus Gag mutant that is defective in nuclear
cyclingYou can also read
